SMTC Partners With IMAXDI to Build Innovative Medical Devices
SMTC and IMAXDI Introducing a New Wireless Medical Device Platform to be
Manufactured at SMTC's San Jose Facility
TORONTO, March 7, 2013 (GLOBE NEWSWIRE) -- SMTC Corporation (Nasdaq:SMTX)
("SMTC"), a global electronics manufacturing services provider, announces that
they have signed a manufacturing agreement with IMAXDI, a leading Spanish
engineering and product innovation company that specializes in the development
of medical devices and related applications. SMTC have been contracted to
build a state-of-the-art mobile communications medical device called 'mBeat'
at SMTC's ISO13485 certified facility in San Jose California.
The 'mBeat' is a mobile communications platform which captures patient vital
sign data through a series of portable wireless sensors. The device allows
critical biomedical data to be transmitted in real-time from the patient to
healthcare providers regardless of their location. Diagnostic-quality data may
be viewed and analyzed at their tablet computers, smartphones or PCs, using
existing mobile communication networks.
Through this new agreement, SMTC will provide IMAXDI with a range of
manufacturing and service solutions from their San Jose facility in order to
support the launch of the 'mBeat' medical product. These services include
design engineering, new product introduction (NPI) support, printed circuit
board assembly (PCBA), final device manufacturing and global supply chain and
For the product design, SMTC will utilize the expertise and knowledge of their
design partner, Idneo, to provide IMAXDI with accelerated product compliance
and certifications in order to reduce time-to-market. Idneo's expertise covers
a wide range of specialities, including design and engineering of embedded
software, mechanical 3D design of products and packaging solutions, design of
both analog and digital hardware, design of power circuits and EMC solutions
(Electro-Magnetic Compatibility) to global customers in multiple markets.
"The level of design support, engineering expertise and manufacturing
capabilities, combined with the service flexibility offered to us by SMTC,
represents real value for IMAXDI," said Miguel Moure, President and CEO of
"IMAXDI is a truly innovative company, and we are very excited to be
partnering with them in manufacturing this product," said Joel Bustos, Vice
President and General Manager of SMTC San Jose. "We look forward to supporting
and growing the 'mBeat' medical product line through our San Jose facility.
About IMAXDI: IMAXDI Real Innovation is a European biomedical engineering
company focused on developing new and disruptive technologies and products to
change the way cardiological telediagnosis is being delivered. IMAXDI brings
concepts such as full mobility, wireless communications or real-time access to
expert diagnosis, to the enterprise and consumer market connecting healthcare
providers, professionals and patients anytime, anywhere. With a deep knowledge
both on hardware and software design and development, and a multi-skilled team
with doctors and engineers, IMAXDI is leading the mHealth innovation path in
Europe. The goal: improving healthcare services delivery through new mobility
technologies, guaranteeing medical quality data everywhere. IMAXDI´s
go-to-marketing strategy includes both direct sales to distribution channel
and flexible partnerships with key players in local countries worldwide.
IMAXDI is an ISO 9001 and ISO 13485 certified company.
About SMTC Corporation: SMTC Corporation, founded in 1985, is a mid-size
provider of end-to-end electronics manufacturing services (EMS) including PCBA
production, systems integration and comprehensive testing services, enclosure
fabrication, as well as product design, sustaining engineering and supply
chain management services. SMTC facilities span a broad footprint in the
United States, Canada, Mexico, and China, with more than 2,300 employees. SMTC
services extend over the entire electronic product life cycle from the
development and introduction of new products through to the growth, maturity
and end-of-life phases. SMTC offers fully integrated contract manufacturing
services with a distinctive approach to global original equipment
manufacturers (OEMs) and emerging technology companies primarily within
industrial, computing and communication market segments. SMTC was recognized
in 2012 by Frost & Sullivan with the Global EMS Award for Product Quality
Leadership and 2013 with the North American Growth Leadership Award in the EMS
industry, as one of the fastest growth companies in 2012.
SMTC is a public company incorporated in Delaware with its shares traded on
the NASDAQ Global Market under the symbol SMTX. For further information on
SMTC Corporation, please visit our website at www.smtc.com.
The SMTC Corporation logo is available at
Note for Investors: The statements contained in this release that are not
purely historical, including our expectations regarding continued revenue and
earnings growth in 2013, are forward-looking statements which involve risk and
uncertainties that could cause actual results to differ materially from those
expressed in the forward-looking statements. These statements may be
identified by their use of forward looking terminology such as "believes,"
"expect," "may," "should," "would," "will," "intends," "plans," "estimates,"
"anticipates" and similar words, and include, but are not limited to,
statements regarding the expectations, intentions or strategies of SMTC
Corporation. For these statements, we claim the protection of the safe harbor
for forward-looking statements provisions contained in the Private Securities
Litigation Reform Act of 1995. Risks and uncertainties that may cause future
results to differ from forward-looking statements include the challenges of
managing quickly expanding operations and integrating acquired companies,
fluctuations in demand for customers' products and changes in customers'
product sources, competition in the EMS industry, component shortages, and
others discussed in the Company's most recent filings with securities
regulators in the United States and Canada. The forward-looking statements
contained in this release are made as of the date hereof and the Company
assumes no obligation to update the forward-looking statements, or to update
the reasons why actual results could differ materially from those projected in
the forward-looking statements.
CONTACT: IMAXDI Inquiries:
Chief Executive Officer
Telephone: +34 986 092 957
Investor Relations Information:
President and Chief Executive Officer
Telephone: (905) 413.1272
John Nesbett/Jennifer Belodeau
Institutional Marketing Services (IMS)
Telephone: (203) 972-9200
Public Relations Information:
Director of Marketing
Telephone: (905) 413.1188
SMTC Corporation Logo
Press spacebar to pause and continue. Press esc to stop.